HUMANOVA Revenue and Competitors
Estimated Revenue & Valuation
- HUMANOVA's estimated annual revenue is currently $3.8M per year.
- HUMANOVA's estimated revenue per employee is $112,000
Employee Data
- HUMANOVA has 34 Employees.
- HUMANOVA grew their employee count by 3% last year.
HUMANOVA's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Konsult | Reveal Email/Phone |
2 | Kommunikationsansvarig | Reveal Email/Phone |
HUMANOVA Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $14.1M | 101 | 5% | N/A | N/A |
#2 | $1.6M | 19 | -71% | N/A | N/A |
#3 | $212.8M | 1063 | 5% | $65M | N/A |
#4 | $6.8M | 54 | 8% | N/A | N/A |
#5 | $12.9M | 92 | 2% | $23.1M | N/A |
#6 | $1M | 12 | N/A | N/A | N/A |
#7 | $106.5M | 599 | -17% | $2.3M | N/A |
#8 | $35.6M | 231 | 6% | N/A | N/A |
#9 | $38.3M | 249 | 5% | N/A | N/A |
#10 | $45M | 299 | -4% | $102.6M | N/A |
What Is HUMANOVA?
N/A
Total Funding
34
Number of Employees
$3.8M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
HUMANOVA News
2022-04-13 - Michigan Judge Declares She Will Preside Over Planned Parenthood Case
Despite Her Prior Representation and Donations
Preimplantation loss of fertilized human ova: estimating the unobservable. Human reproduction (Oxford, England) 35.4 (2020): 743-750.
2022-04-13 - Patenting Stem Related Inventions In India - Intellectual ...
Pluripotent stem cells are used, processed, and human embryonic stem cell lines are created in the HESCRs. Human embryos are not the same thing...
2022-03-22 - One futuristic alien technology could confirm the existence of advanced
life in space
As Matloff summarizes it, A Von Neumann probe could carry fertilized human ova to be raised robotically and populate in-space habitats...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $8.5M | 34 | 6% | N/A |
#2 | $6M | 34 | -11% | N/A |
#3 | $5.7M | 34 | -6% | N/A |
#4 | $4.1M | 34 | 3% | N/A |
#5 | $35M | 34 | -6% | N/A |